Author:
Midha Kamal K.,McKay Gordon
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997–2000. Ann Intern Med. 2005;142:891–7.
2. Shrank WH, Cox ER, Fisher MA, Mehta J, Choudhry NK. Patients’ perceptions of generic medications. Health Aff. 2009;28:546–56.
3. Chow S-C, Liu J-P. History of bioequivalence studies. In: Design and Analysis of Bioavailability and Bioequivalence Studies. Chapman and Hall/CRC Biostatistics Series, 2009; p. 3–8.
4. Anderson S, Hauck WW. A new procedure for testing equivalence in comparative bioavailability and other clinical trials. Commun Stat—Theory Methods. 1983;12:1–11.
5. Schuirmann DJ. On hypothesis testing to determine if the mean of a normal distribution is contained in a known interval. Biometrics. 1981;37:617. abstract.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献